{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T11:19:28Z","timestamp":1786965568710,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.ypmed.2019.105927","type":"journal-article","created":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T11:20:57Z","timestamp":1574162457000},"page":"105927","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Risk prediction of cervical abnormalities: The value of sociodemographic and lifestyle factors in addition to HPV status"],"prefix":"10.1016","volume":"130","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5850-8814","authenticated-orcid":false,"given":"Dani\u00eblle","family":"van der Waal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruud L.M.","family":"Bekkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5548-4557","authenticated-orcid":false,"given":"St\u00e8fanie","family":"Dick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte H.","family":"Lenselink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon F.A.G.","family":"Massuger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem J.G.","family":"Melchers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Channa E.","family":"Schmeink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert G.","family":"Siebers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireille J.M.","family":"Broeders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 5","key":"10.1016\/j.ypmed.2019.105927_bb0005","doi-asserted-by":"crossref","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer","volume":"30","author":"Arbyn","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.ypmed.2019.105927_bb0010","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/rmv.416","article-title":"Epidemiological and clinical aspects of human papillomavirus detection in the prevention of cervical cancer","volume":"14","author":"Bekkers","year":"2004","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.ypmed.2019.105927_bb0015","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens\u2014part B: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ypmed.2019.105927_bb0020","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ypmed.2019.105927_bb0025","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/jnci\/djj067","article-title":"Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention","volume":"98","author":"Castellsagu\u00e9","year":"2006","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ypmed.2019.105927_bb0030","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/ijc.21279","article-title":"Hormonal contraceptive use, pregnancy and parity, and the risk of cervical intraepithelial neoplasia 3 among oncogenic HPV DNA-positive women with equivocal or mildly abnormal cytology","volume":"117","author":"Castle","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ypmed.2019.105927_bb0035","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/LGT.0b013e3182730fec","article-title":"A cervical abnormality risk prediction model: can we use clinical information to predict which patients with ASCUS\/LSIL Pap tests will develop CIN 2\/3 or AIS?","volume":"17","author":"Charlton","year":"2013","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.ypmed.2019.105927_bb0040","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S1470-2045(05)70086-3","article-title":"Carcinogenicity of human papillomaviruses","volume":"6","author":"Cogliano","year":"2005","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ypmed.2019.105927_bb0045","doi-asserted-by":"crossref","first-page":"g7594","DOI":"10.1136\/bmj.g7594","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"350","author":"Collins","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.ypmed.2019.105927_bb0050","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ijc.21955","article-title":"Overview of the European and North American studies on HPV testing in primary cervical cancer screening","volume":"119","author":"Cuzick","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ypmed.2019.105927_bb0055","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1080\/14737140.2016.1232166","article-title":"Triage of high-risk HPV positive women in cervical cancer screening","volume":"16","author":"Ebisch","year":"2016","journal-title":"Expert. Rev. Anticancer. Ther."},{"key":"10.1016\/j.ypmed.2019.105927_bb0060","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/jnci\/djy013","article-title":"Breast cancer risk model requirements for counseling, prevention, and screening","volume":"110","author":"Gail","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ypmed.2019.105927_bb0065","author":"Health Council of the Netherlands"},{"key":"10.1016\/j.ypmed.2019.105927_bb0070","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/ijc.21953","article-title":"Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies","volume":"119","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ypmed.2019.105927_bb0075","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/ijc.22357","article-title":"Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies","volume":"120","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ypmed.2019.105927_bb0080","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pvr.2015.06.006","article-title":"European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination","volume":"1","author":"von Karsa","year":"2015","journal-title":"Papillomavirus Res"},{"key":"10.1016\/j.ypmed.2019.105927_bb0085","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/ijc.28982","article-title":"Risk evaluation for the development of cervical intraepithelial neoplasia: development and validation of risk-scoring schemes","volume":"136","author":"Lee","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ypmed.2019.105927_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003743","article-title":"Sexual behaviour and HPV infections in 18 to 29 year old women in the pre-vaccine era in the Netherlands","volume":"3","author":"Lenselink","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.ypmed.2019.105927_bb0095","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ygyno.2012.11.003","article-title":"The role of co-factors in the progression from human papillomavirus infection to cervical cancer","volume":"128","author":"Luhn","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ypmed.2019.105927_bb0100","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(02)08150-3","article-title":"Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study","volume":"359","author":"Moreno","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ypmed.2019.105927_bb0105","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0140-6736(02)08151-5","article-title":"Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study","volume":"359","author":"Mu\u00f1oz","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ypmed.2019.105927_bb0110","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/2046-4053-2-35","article-title":"Screening for cervical cancer: a systematic review and meta-analysis","volume":"2","author":"Peirson","year":"2013","journal-title":"Syst Rev"},{"key":"10.1016\/j.ypmed.2019.105927_bb0115","first-page":"805","article-title":"Smoking and cervical cancer: pooled analysis of the IARC multi-centric case-control study","volume":"14","author":"Plummer","year":"2003","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ypmed.2019.105927_bb0120","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/ijc.26056","article-title":"Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening","volume":"130","author":"Rijkaart","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ypmed.2019.105927_bb0125","author":"Rijksinstituut voor Volksgezondheid en Milieu (RIVM) [National Institute for Public Health and the Environment]"},{"key":"10.1016\/j.ypmed.2019.105927_bb0130","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial","volume":"11","author":"Ronco","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ypmed.2019.105927_bb0135","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ypmed.2019.105927_bb0140","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/j.vaccine.2009.12.042","article-title":"Determinants for HPV vaccine uptake in the Netherlands: a multilevel study","volume":"28","author":"Rondy","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.ypmed.2019.105927_bb0145","first-page":"297","article-title":"A risk prediction model to allow personalized screening for cervical cancer","volume":"29","author":"Rothberg","year":"2018","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ypmed.2019.105927_bb0150","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/ijc.28666","article-title":"Smoking as a major risk factor for cervical cancer and pre-cancer: results from the EPIC cohort","volume":"135","author":"Roura","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ypmed.2019.105927_bb0155","article-title":"The influence of hormonal factors on the risk of developing cervical cancer and pre-cancer: results from the EPIC cohort","volume":"11","author":"Roura","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ypmed.2019.105927_bb0160","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ypmed.2019.105927_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027937","article-title":"Human papillomavirus persistence in young unscreened women, a prospective cohort study","volume":"6","author":"Schmeink","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ypmed.2019.105927_bb0170","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/(SICI)1097-0215(19990219)84:1<69::AID-IJC13>3.0.CO;2-J","article-title":"Integrated approach to prediction of cervical intra-epithelial neoplasia status through a case-control study","volume":"84","author":"Sengupta","year":"1999","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ypmed.2019.105927_bb0175","series-title":"Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating","author":"Steyerberg","year":"2009"},{"key":"10.1016\/j.ypmed.2019.105927_bb0180","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/(SICI)1097-0258(20000430)19:8<1059::AID-SIM412>3.0.CO;2-0","article-title":"Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data sets","volume":"19","author":"Steyerberg","year":"2000","journal-title":"Stat. Med."},{"key":"10.1016\/j.ypmed.2019.105927_bb0185","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0895-4356(03)00047-7","article-title":"Internal and external validation of predictive models: a simulation study of bias and precision in small samples","volume":"56","author":"Steyerberg","year":"2003","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.ypmed.2019.105927_bb0190","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1158\/1055-9965.EPI-05-0577","article-title":"Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys","volume":"15","author":"Vaccarella","year":"2006","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ypmed.2019.105927_bb0195","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1158\/1055-9965.EPI-06-0556","article-title":"Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys","volume":"15","author":"Vaccarella","year":"2006","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ypmed.2019.105927_bb0200","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/ije\/dyn033","article-title":"Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV prevalence surveys","volume":"37","author":"Vaccarella","year":"2008","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.ypmed.2019.105927_bb0205","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12874-016-0239-7","article-title":"Assessment of predictive performance in incomplete data by combining internal validation and multiple imputation","volume":"16","author":"Wahl","year":"2016","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.ypmed.2019.105927_bb0210","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J. Pathol."},{"key":"10.1016\/j.ypmed.2019.105927_bb0215","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1158\/1055-9965.EPI-08-0591","article-title":"Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants","volume":"18","author":"Wang","year":"2009","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ypmed.2019.105927_bb0220","unstructured":"Werkgroep CIN, AIS, en VAIN [Working group CIN, AIS, and VAIN]. CIN, AIS en VAIN Landelijke richtlijn (Versie: 1.0) [CIN, AIS, and VAIN National guideline (Version 1.0)]. 2015. Available from: https:\/\/www.oncoline.nl\/cin-ais-en-vain."}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743519304104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743519304104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T10:06:36Z","timestamp":1758794796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091743519304104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":44,"alternative-id":["S0091743519304104"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2019.105927","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk prediction of cervical abnormalities: The value of sociodemographic and lifestyle factors in addition to HPV status","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2019.105927","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105927"}}